Evonik Industries AG Receives "Hold" Recommendation from Parmantier & Cie. GmbH

Evonik Industries AG has been classified with a "Hold" recommendation by Parmantier & Cie. GmbH, according to their recent research. The target price for Evonik is set at EUR 20.50, with a six-month outlook. The research is part of a broader report titled "European Chemicals: The 2027 Cycle," highlighting the German chemical sector's trajectory.

The report suggests the 2027 cycle may vary from simple industrial recovery, focusing on restructuring, capacity rationalization, and selective consolidation. It evaluates factors such as energy competitiveness and Chinese export pressure, examining their effects on operating leverage, cash flow, and portfolio management.

BASF and Evonik are specifically noted in the context of exploratory merger talks, although no firm agreements have been made. The report emphasizes a nuanced analysis of the sector rather than a universal recovery prediction.